IRIS Accounts Production v24.3.0.553 01377934 Board of Directors 1.8.23 31.7.24 31.7.24 0 0 false true false false true false Fair value model iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh013779342023-07-31013779342024-07-31013779342023-08-012024-07-31013779342022-07-31013779342022-08-012023-07-31013779342023-07-3101377934ns15:EnglandWales2023-08-012024-07-3101377934ns14:PoundSterling2023-08-012024-07-3101377934ns10:Director12023-08-012024-07-3101377934ns10:PrivateLimitedCompanyLtd2023-08-012024-07-3101377934ns10:SmallEntities2023-08-012024-07-3101377934ns10:AuditExempt-NoAccountantsReport2023-08-012024-07-3101377934ns10:SmallCompaniesRegimeForDirectorsReport2023-08-012024-07-3101377934ns10:SmallCompaniesRegimeForAccounts2023-08-012024-07-3101377934ns10:FullAccounts2023-08-012024-07-3101377934ns10:Director22023-08-012024-07-3101377934ns10:CompanySecretary12023-08-012024-07-3101377934ns10:RegisteredOffice2023-08-012024-07-3101377934ns5:CurrentFinancialInstruments2024-07-3101377934ns5:CurrentFinancialInstruments2023-07-3101377934ns5:ShareCapital2024-07-3101377934ns5:ShareCapital2023-07-3101377934ns5:FurtherSpecificReserve2ComponentTotalEquity2024-07-3101377934ns5:FurtherSpecificReserve2ComponentTotalEquity2023-07-3101377934ns5:RetainedEarningsAccumulatedLosses2024-07-3101377934ns5:RetainedEarningsAccumulatedLosses2023-07-3101377934ns5:PlantMachinery2023-08-012024-07-3101377934ns5:ComputerEquipment2023-08-012024-07-3101377934ns5:PlantMachinery2023-07-3101377934ns5:ComputerEquipment2023-07-3101377934ns5:PlantMachinery2024-07-3101377934ns5:ComputerEquipment2024-07-3101377934ns5:PlantMachinery2023-07-3101377934ns5:ComputerEquipment2023-07-3101377934ns5:RetainedEarningsAccumulatedLosses2023-07-3101377934ns5:FurtherSpecificReserve2ComponentTotalEquity2023-07-3101377934ns5:RetainedEarningsAccumulatedLosses2023-08-012024-07-31
REGISTERED NUMBER: 01377934 (England and Wales)


















UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 JULY 2024

FOR

MEDICENTRES LIMITED

MEDICENTRES LIMITED (REGISTERED NUMBER: 01377934)






CONTENTS OF THE FINANCIAL STATEMENTS
for the Year Ended 31 July 2024




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


MEDICENTRES LIMITED

COMPANY INFORMATION
for the Year Ended 31 July 2024







DIRECTORS: Dr B W O'Brien
Mrs C O'Brien





SECRETARY: Mrs C O'Brien





REGISTERED OFFICE: Beech Croft
51 Ruff Lane
Ormskirk
Lancashire
L39 4UL





REGISTERED NUMBER: 01377934 (England and Wales)





ACCOUNTANTS: Fairhurst Accountants Ltd
Chartered Accountants
Douglas Bank House
Wigan Lane
Wigan
Lancashire
WN1 2TB

MEDICENTRES LIMITED (REGISTERED NUMBER: 01377934)

BALANCE SHEET
31 July 2024

2024 2023
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 2,933 1,288
Investment property 5 282,000 265,000
284,933 266,288

CURRENT ASSETS
Cash at bank and in hand 59,897 77,753

CREDITORS
Amounts falling due within one year 6 2,372 4,376
NET CURRENT ASSETS 57,525 73,377
TOTAL ASSETS LESS CURRENT
LIABILITIES

342,458

339,665

CAPITAL AND RESERVES
Called up share capital 1,000 1,000
Other reserves 7 50,955 42,211
Retained earnings 7 290,503 296,454
SHAREHOLDERS' FUNDS 342,458 339,665

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 July 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 July 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 6 January 2025 and were signed on its behalf by:





Dr B W O'Brien - Director


MEDICENTRES LIMITED (REGISTERED NUMBER: 01377934)

NOTES TO THE FINANCIAL STATEMENTS
for the Year Ended 31 July 2024

1. STATUTORY INFORMATION

Medicentres Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention as modified by the revaluation of certain assets.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off the cost less estimated residual value of each asset over its estimated useful life.
Plant and machinery - 25% on reducing balance
Computer equipment - 25% on reducing balance

Tangible fixed assets are recorded at cost or valuation, less depreciation and impairment.

Impairment of assets
At each reporting date assets are reviewed to determine whether there is any indication that those assets have suffered an impairment loss. If there is an indication of possible impairment, the recoverable amount of any affected asset is estimated and compared with its carrying amount. If the estimated recoverable amount is lower, the carrying amount is reduced to its estimated recoverable amount, and an impairment loss is recognised immediately in the profit and loss.

Where an impairment loss subsequently reverses, the carrying amount of each asset is increased to the revised estimate of its recoverable amount, to the extent that the increased carrying amount does not exceed the carrying amount that would have been determined (net of depreciation) had no impairment loss been recognised for the asset in prior years. A reversal of an impairment loss is recognised as income immediately.

Investment property
Investment property is shown at most recent valuation. Any aggregate surplus or deficit arising from changes in fair value is recognised in profit or loss.

Deferred tax is provided on these gains at the rate expected to apply when the property is sold.

Financial instruments
Short term trade creditors are measured at transaction price. Financial liabilities that have no stated interest rate and are payable within one year shall be measured at the undiscounted amount due.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


MEDICENTRES LIMITED (REGISTERED NUMBER: 01377934)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the Year Ended 31 July 2024

2. ACCOUNTING POLICIES - continued
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was NIL (2023 - NIL).

4. TANGIBLE FIXED ASSETS
Plant and Computer
machinery equipment Totals
£    £    £   
COST
At 1 August 2023 9,688 5,430 15,118
Additions - 2,623 2,623
At 31 July 2024 9,688 8,053 17,741
DEPRECIATION
At 1 August 2023 9,625 4,205 13,830
Charge for year 16 962 978
At 31 July 2024 9,641 5,167 14,808
NET BOOK VALUE
At 31 July 2024 47 2,886 2,933
At 31 July 2023 63 1,225 1,288

5. INVESTMENT PROPERTY
Total
£   
FAIR VALUE
At 1 August 2023 265,000
Additions 8,256
Revaluations 8,744
At 31 July 2024 282,000
NET BOOK VALUE
At 31 July 2024 282,000
At 31 July 2023 265,000

The investment properties were valued on 31 July by the directors who consider it not materially different to the value as stated in these financial statements.

MEDICENTRES LIMITED (REGISTERED NUMBER: 01377934)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the Year Ended 31 July 2024

5. INVESTMENT PROPERTY - continued

Fair value at 31 July 2024 is represented by:
£   
Valuation in 2004 17,898
Valuation in 2006 34,313
Valuation in 2013 5,000
Valuation in 2020 (40,000 )
Valuation in 2023 25,000
Valuation in 2024 8,744
Cost 231,045
282,000

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Other creditors 2,372 4,376

7. RESERVES
Retained Other
earnings reserves Totals
£    £    £   

At 1 August 2023 296,454 42,211 338,665
Deficit for the year (4,027 ) (4,027 )
Dividends (1,924 ) (1,924 )
Surplus on revaluation - 8,744 8,744
At 31 July 2024 290,503 50,955 341,458